C. Mollereau

发表

Heterologous Regulation of Mu-Opioid (MOP) Receptor Mobility in the Membrane of SH-SY5Y Cells*

Kévin Carayon, L. Salomé, S. Mazères, 2014, The Journal of Biological Chemistry.

Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain.

C. Topham, J. Meunier, L. Moulédous, 2000, Molecular pharmacology.

Nucleotide sequence of a human cannabinoid receptor cDNA.

M. Parmentier, G. Vassart, C. Mollereau, 1990, Nucleic acids research.

Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.

J. Meunier, L. Moulédous, C. Mollereau, 1999, Molecular pharmacology.

Functional differences between NPFF1 and NPFF2 receptor coupling: High intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPγS binding

H. Vaudry, J. Leprince, C. Mollereau, 2007, Neuropharmacology.

Functional characterization of a human receptor for neuropeptide FF and related peptides

M. Parmentier, G. Vassart, C. Mollereau, 2001, British journal of pharmacology.

Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226

M. Parmentier, R. Quirion, C. Mollereau, 2001, British journal of pharmacology.

NPYFa, A Chimeric Peptide of Met‐Enkephalin, and NPFF Induces Tolerance‐Free Analgesia

C. Mollereau, S. Pasha, Krishan Kumar, 2016, Chemical biology & drug design.

Tissue distribution of the opioid receptor-like (ORL1) receptor

L. Moulédous, C. Mollereau, 2000, Peptides.

Analysis of 5000 year-old human teeth using optimized large-scale and targeted proteomics approaches for detection of sex-specific peptides.

C. Froment, O. Burlet-Schiltz, C. Mollereau, 2020, Journal of proteomics.

Phosphoproteomic analysis of the mouse brain mu‐opioid (MOP) receptor

S. Schulz, C. Froment, O. Burlet-Schiltz, 2015, FEBS letters.

Identification and Functional Characterization of the Phosphorylation Sites of the Neuropeptide FF2 Receptor*

C. Froment, O. Burlet-Schiltz, L. Moulédous, 2014, The Journal of Biological Chemistry.

The repertoire of family A-peptide GPCRs in archaic hominins

G. Renaud, C. Mollereau, X. Mata, 2019, Peptides.

N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.

M. Keller, A. Buschauer, C. Mollereau, 2015, Journal of medicinal chemistry.

Pharmacological characterization of the mouse NPFF2 receptor

F. Bihel, J. Bourguignon, M. Schmitt, 2010, Peptides.

Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF1 and NPFF2) receptors

C. Mollereau, H. Mazarguil, F. Talmont, 2009, Neurochemistry International.

Correction for Simonin et al., RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia

M. Parmentier, J. Bourguignon, J. Jhamandas, 2006, Proceedings of the National Academy of Sciences.

Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.

F. Serre, C. Mollereau, H. Mazarguil, 2005, Biochemical and biophysical research communications.

Neuropeptide FF (NPFF) Analogs Functionally Antagonize Opioid Activities in NPFF2 Receptor-Transfected SH-SY5Y Neuroblastoma Cells

C. Mollereau, H. Mazarguil, J. Zajac, 2005, Molecular Pharmacology.

Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands

S. Rice, C. Mollereau, H. Mazarguil, 2002, Neuroscience.

Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.

M. Parmentier, R. Quirion, C. Mollereau, 2002, European journal of pharmacology.

Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids

M. Parmentier, J. Meunier, C. Mollereau, 1996, FEBS letters.

Study of the N-terminal part of peptidic selective NPFF2 agonists

C. Mollereau, H. Mazarguil, G. Czaplicki, 2012, Peptides.

Different domains of the ORL1 and κ‐opioid receptors are involved in recognition of nociceptin and dynorphin A

J. Meunier, C. Mollereau, C. Moisand, 1998, FEBS letters.

Comparison of the structure‐activity relationships of nociceptin and dynorphin A using chimeric peptides

J. Meunier, C. Mollereau, H. Mazarguil, 1997, FEBS letters.

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

M. Parmentier, J. Bourguignon, J. Jhamandas, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.

F. Bihel, J. Bourguignon, F. Simonin, 2012, Bioorganic & medicinal chemistry letters.

Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments

H. Meziane, F. Bihel, J. Bourguignon, 2012, British journal of pharmacology.

Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene.

M. Parmentier, G. Vassart, J. Meunier, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

Marc Parmentier, Pascual Ferrara, Lawrence Toll, 1995, Nature.

ORL1, a novel member of the opioid receptor family

G Vassart, M. Parmentier, P. Chalon, 1994, FEBS letters.

Protein sequence comparison of human and non-human primate tooth proteomes

C. Froment, O. Burlet-Schiltz, C. Mollereau, 2021, Journal of Proteomics.

Neanderthal and Denisova tooth protein variants in present-day humans

Clément Zanolli, C. Mollereau, C. Zanolli, 2017, PloS one.

Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.

J. Meunier, C. Mollereau, H. Mazarguil, 1997, European journal of pharmacology.

Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

G Vassart, M. Parmentier, G. Vassart, 1996, Biochemistry.

The G Protein–coupled Receptor Family and One of Its Members, the TSH Receptor a

P. Vanderhaeghen, M. Parmentier, J. Parma, 1995, Annals of the New York Academy of Sciences.

ChemR23, a putative chemoattractant receptor, is expressed in monocyte‐derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV‐1 strains

R. Doms, M. Parmentier, V. Verhasselt, 1998, European journal of immunology.

Loss of Morphine Reward and Dependence in Mice Lacking G Protein–Coupled Receptor Kinase 5

S. Schulz, P. Law, L. Moulédous, 2014, Biological Psychiatry.

Pharmacological insight into the activation of the human neuropeptide FF2 receptor

Rémi Veneziano, L. Moulédous, C. Mollereau, 2020, Peptides.

Neuropeptide FF receptor modulates potassium currents in a dorsal root ganglion cell line

C. Mollereau, J. Zajac, M. Roumy, 2011, Pharmacological reports : PR.

Opioid‐modulating properties of the neuropeptide FF system

L. Moulédous, C. Mollereau, J. Zajac, 2010, BioFactors.

Solubilization and functional reconstitution of human neuropeptide FF2 receptors.

C. Mollereau, I. Muller, J. Zajac, 2010, Analytical biochemistry.

Physical Association between Neuropeptide FF and μ-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity*

S. Mazères, C. Mollereau, J. Zajac, 2007, Journal of Biological Chemistry.

Structure-activity relationships of neuropeptide FF: role of C-terminal regions

C. Mollereau, H. Mazarguil, J. Zajac, 2001, Peptides.

[125I]EYF: a new high affinity radioligand to neuropeptide FF receptors

C. Mollereau, H. Mazarguil, J. Zajac, 2001, Peptides.

Solubilization and reconstitution of the mu-opioid receptor expressed in human neuronal SH-SY5Y and CHO cells

L. Moulédous, C. Mollereau, F. Talmont, 2014, Peptides.

Evidence for a new type of opioid binding site in the brain of the frog Rana ridibunda.

J. Meunier, C. Mollereau, H. Mazarguil, 1988, European journal of pharmacology.

Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system

S. Schiffmann, M. Parmentier, J. Vanderhaeghen, 1999, Neuroscience.

[Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.

J. Meunier, C. Mollereau, C. Moisand, 1998, European journal of pharmacology.

Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model

C. Mollereau, J. Zajac, M. Roumy, 2006, Peptides.

Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area

C. Mollereau, Jin-Chung Chen, J. Zajac, 2011, Neuroscience Letters.

Structure–activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives

C. Mollereau, C. McCurdy, G. Chevé, 2006, Peptides.

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors

S. Cutler, C. Mollereau, S. Eans, 2014, Journal of medicinal chemistry.

Hearing Sensitivity of Primates: Recurrent and Episodic Positive Selection in Hair Cells and Stereocilia Protein-Coding Genes

P. Balaresque, Sylvain Cussat-Blanc, C. Mollereau, 2021, Genome biology and evolution.

Expression of members of the putative olfactory receptor gene family in mammalian germ cells

S. Schiffmann, M. Parmentier, S. Schurmans, 1992, Nature.

Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding.

H. Vaudry, J. Leprince, C. Mollereau, 2007, Neuropharmacology.

A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)–p85 to Filamin A Negatively Controls the PI3K Pathway

S. Schulz, S. Najib, C. Bousquet, 2011, Molecular and Cellular Biology.

Opioid-modulating peptides: mechanisms of action.

C. Mollereau, J. Zajac, M. Roumy, 2005, Current topics in medicinal chemistry.

Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesia.

F. Bihel, J. Bourguignon, F. Simonin, 2015, ACS chemical neuroscience.

Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.

J. Svobodová, M. Keller, A. Buschauer, 2016, Journal of medicinal chemistry.

Denatured G-Protein Coupled Receptors as Immunogens to Generate Highly Specific Antibodies

L. Moulédous, C. Mollereau, F. Talmont, 2012, PloS one.

Functional characterization of novel G protein-coupled receptors involved in nociception and HIV-1 infection

R. Doms, M. Parmentier, J. Rucker, 1997 .

Molecular cloning of a human cannabinoid receptor which is also expressed in testis.

G Vassart, M. Parmentier, C. Gérard, 1991, The Biochemical journal.

HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants

S. Schulz, C. Froment, O. Burlet-Schiltz, 2020, Communications Biology.

Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.

J. Galzi, B. Ilien, J. Meunier, 1990, Journal of medicinal chemistry.

GRK2 Protein-mediated Transphosphorylation Contributes to Loss of Function of μ-Opioid Receptors Induced by Neuropeptide FF (NPFF2) Receptors*

C. Froment, O. Burlet-Schiltz, L. Moulédous, 2012, The Journal of Biological Chemistry.

Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors

C. Mollereau, J. Zajac, M. Roumy, 2007, Peptides.

Enamel proteins reveal biological sex and genetic variability within southern African Paranthropus

T. Marquès-Bonet, J. Olsen, Esther Lizano, 2023, bioRxiv.

Modulation by Neuropeptide FF of the interaction of Mu-opioid (MOP) receptor with G-proteins

L. Moulédous, C. Mollereau, J. Zajac, 2010, Neurochemistry International.

Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.

B. Roux, L. Moulédous, C. Mollereau, 2008, Biochemical and biophysical research communications.

5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.

J. Meunier, C. Mollereau, H. Mazarguil, 1988, The Journal of biological chemistry.

A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)–p85 to Filamin A Negatively Controls the PI3K Pathway

S. Schulz, S. Najib, C. Bousquet, 2011, Molecular and Cellular Biology.

Comparison of human and non-human primate tooth proteomes as a basis for the study of ancient proteins.

C. Froment, O. Burlet-Schiltz, C. Mollereau, 2020, Journal of proteomics.

The high-affinity interleukin 8 receptor gene (IL8RA) maps to the 2q33-q36 region of the human genome: cloning of a pseudogene (IL8RBP) for the low-affinity receptor.

M. Parmentier, M. Mattei, G. Vassart, 1993, Genomics.